Oculus Innovative Sciences Inc.

Oculus Innovative Sciences Inc. is a commercial healthcare company that develops, manufactures and markets a family of products based upon the Microcyn technology platform, which includes new formulations designed to significantly reduce the need for antibiotics as it reduces infections. Several solutions derived from this platform have demonstrated, in a variety of research and investigational studies, to increase blood flow to the wound site, reduce both inflammation and pain while assisting in faster wound closure, and the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria, viruses, fungi and spores.